Results 181 to 190 of about 107,712 (298)

Hematological analysis of alpha-thalassemia: A single-center, retrospective clinical study. [PDF]

PLoS One
Zheng L, Yin N, Wang M, Huang H, Lin N, Zhang S, Su L, Xu L.   +7 more
europepmc   +1 more source

A Multicenter Retrospective Study of HbH in China Including 1421 Patients Over a 12‐Year Timespan

eJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Background Hemoglobin H (HbH) disease is a relatively common genetic disorder worldwide. However, the lack of long‐term follow‐up studies involving large patient cohorts has limited our understanding of its clinical features, disease progression, and outcomes.
Hangning Shang, Shijun Xu, Yaqing Zhang, Junbin Liang, Pingping Li, Lihong Zeng, Yufang Gu, Haiying Li, Weiping Wei, Zhen Lu, Zan Chen, Rongying Gong, Xinhua Zhang, Hui Xu, Li Wang   +14 more
wiley   +1 more source

Multiclass classification of thalassemia types using complete blood count and HPLC data with machine learning. [PDF]

Sci Rep
Nasir MU, Zubair M, Naseem MT, Shahzad T, Saeed A, Adnan KM, Gandomi AH.   +6 more
europepmc   +1 more source

Potassium permeability in β-thalassemia minor red blood cells [PDF]

, 1972
Robert B. Gunn, David N. Silvers, Wendell F. Rosse   +2 more
openalex   +1 more source

The α‐Thalassemias

Annals of the New York Academy of Sciences, 1990
Higgs, D, Wood, W, Jarman, A, Vickers, M, Wilkie, A, Lamb, J, Vyas, P, Bennett, J   +7 more
openaire   +5 more sources

Treatment Experience Using a Micro‐Induction Buprenorphine Protocol for Chronic Pain in Pediatric Sickle Cell Disease

Pediatric Blood &Cancer, Volume 72, Issue 8, August 2025.
ABSTRACT Background Patients with sickle cell disease (SCD) experience painful vaso‐occlusive episodes that increase with age; a subset develops chronic pain (CP). CP is usually managed with acute pain management guidelines despite evidence of ineffectiveness.
Ashwin Patel, Grace Kalmus, Carlton Dampier, Ifeyinwa Osunkwo, Tamara New, Beatrice Gee, Elna Saah   +6 more
wiley   +1 more source

Medication Utilization Among Children With Sickle Cell Disease in the United States

Pediatric Blood &Cancer, Volume 72, Issue 8, August 2025.
ABSTRACT Background and Objective The medication management of children with sickle cell disease (SCD), especially since the release of the 2014 National Heart, Lung, and Blood Institute (NHLBI) SCD treatment guidelines, is not well described in the published literature.
Abiodun John Ologunowa, Kelly L. Matson, Jung Eun Lee, Meghan McCormick, Mary L. Greaney, Aisling R. Caffrey   +5 more
wiley   +1 more source

Thalassemia in Bangladesh: progress, challenges, and a strategic blueprint for prevention. [PDF]

Orphanet J Rare Dis
Hossain MS, Islam F, Akhter S, Al Mossabbir A.   +3 more
europepmc   +1 more source

Equal synthesis of α- and β-globin chains in erythroid precursors in heterozygous β-thalassemia [PDF]

, 1972
Yuet Wai Kan, David G. Nathan, Harvey F. Lodish   +2 more
openalex   +1 more source

Incidental Identification of Potentially Affected Individuals Through Expanded Carrier Screening During Preconception or Early Pregnancy

Prenatal Diagnosis, Volume 45, Issue 9, Page 1151-1159, August 2025.
ABSTRACT Objective Expanded carrier screening (ECS) is used to assess the reproductive probability of having an offspring affected by an autosomal recessive or X‐linked recessive genetic disorder. Rarely, a presumably healthy individual may be identified to carry variants that could influence their health.
Yan Lü, Jiazhen Chang, Yulin Jiang, Xiya Zhou, Na Hao, Yiqing Yu, Mengmeng Li, Kaili Yin, Xueting Yang, Qingwei Qi   +9 more
wiley   +1 more source